$216.57

-3.10 (-1.41%)

Weekly Expected Move ±4.4%

$193 $203 $212 $222 $231

NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 56 · $21.3B mcap · 98M float · 0.840% daily turnover · Short 64% of daily vol

Revenue

$5.9B +8.7% ▲

5Y CAGR: +13.8%

Gross Profit

$2.6B +9.3% ▲

5Y CAGR: +14.4%

Operating Income

$1.1B +27.1% ▲

5Y CAGR: +15.0%

Net Income

$785M +27.7% ▲

5Y CAGR: +14.6%

EPS (Diluted)

$7.93 +27.9% ▲

5Y CAGR: +11.4%

EBITDA

$1.1B -18.9% ▼

5Y CAGR: +7.3%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$4.2B	$4.5B	$5.1B	$5.5B	$5.9B
YoY Growth	+35.9%	+7.4%	+13.3%	+6.2%	+8.7%
Cost of Revenue	$2.3B	$2.6B	$2.9B	$3.1B	$3.3B
Gross Profit	$1.9B	$2.0B	$2.2B	$2.4B	$2.6B
Gross Margin	44.6%	43.7%	43.2%	44.0%	44.2%
R&D Expenses	$87M	$98M	$104M	$108M	$113M
SG&A Expenses	$1.3B	$1.1B	$1.3B	$1.3B	$1.4B
Operating Expenses	$1.4B	$1.2B	$1.4B	$1.5B	$1.5B
Operating Income	$478M	$791M	$836M	$867M	$1.1B
Operating Margin	11.3%	17.4%	16.3%	15.9%	18.6%
Interest Expense	$89M	$111M	$144M	$86M	$61M
Income Before Tax	$367M	$680M	$703M	$796M	$1.0B
Tax Expense	$82M	$124M	$150M	$185M	$262M
Net Income	$244M	$107M	$378M	$615M	$785M
Net Margin	5.8%	2.4%	7.4%	11.3%	13.2%
EPS (Diluted)	$2.48	$1.07	$3.81	$6.20	$7.93
EBITDA	$1.0B	$1.3B	$1.4B	$1.4B	$1.1B
Shares Outstanding	98M	100M	99M	99M	99M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$1.3B	$1.1B	$1.3B	$1.3B	$1.4B	$1.5B	$1.4B	$1.5B
Cost of Revenue	$738M	$668M	$707M	$750M	$760M	$839M	$763M	$814M
Gross Profit	$560M	$449M	$572M	$579M	$610M	$641M	$628M	$646M
Gross Margin	43.2%	40.2%	44.7%	43.6%	44.5%	43.3%	45.1%	44.2%
R&D Expenses	$25M	$25M	$26M	$27M	$27M	$28M	$26M	$28M
SG&A Expenses	$308M	$152M	$336M	$329M	$335M	$334M	$354M	$350M
Operating Expenses	$334M	$203M	$387M	$359M	$365M	$425M	$382M	$380M
Operating Income	$226M	$245M	$186M	$220M	$245M	$216M	$246M	$268M
Operating Margin	17.5%	22.0%	14.5%	16.5%	17.9%	14.6%	17.7%	18.4%
Interest Expense	$39M	$36M	$30M	$20M	$19M	$17M	$16M	$15M
Income Before Tax	$190M	$215M	$175M	$195M	$229M	$197M	$232M	$253M
Tax Expense	$41M	$43M	$35M	$44M	$55M	$50M	$54M	$61M
Net Income	$141M	-$1M	$145M	$150M	$174M	$146M	$177M	$192M
Net Margin	10.8%	-0.1%	11.4%	11.3%	12.7%	9.8%	12.8%	13.1%
EPS (Diluted)	$1.42	$-0.01	$1.46	$1.51	$1.75	$1.48	$1.79	$1.94
EBITDA	$369M	$386M	$318M	$330M	$374M	$337M	$367M	$390M
Shares Outstanding	99M	99M	99M	99M	99M	99M	99M	99M

STE NYSE